Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Ambroxol on the Inflammatory Markers and Clinical Outcome of Patients With Diabetic Peripheral Neuropathy

NCT05558878 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05558878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05558878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Ambroxol on the Inflammatory Markers and Clinical Outcome of Patients With Diabetic Peripheral Neuropathy
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2022
Completion date
November 30, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy peripheral